Prosthetic Biologic Valve Endocarditis Caused by a Vancomycin-Resistant (vanA) Enterococcus faecalis: Case Report

REFERENCES

• Centers for Disease Control. Nosocomial enterococci resistant to vancomycin-United States, 1989-1993. MMWR 1993; 42: 597–599.
   PubMedGoogle Scholar
• Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP. Nosocomial bloodstream infections in United States Hospitals: a three-year analysis. Clin Infect Dis 1999; 29: 239–244.
   PubMed Web of Science ®Google Scholar
• NCCLS, (National Committee for Clinical Laboratory Standards). Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically; Fourth Edition: Approved standard M7-A4, vol. 17, No. 2. NCCLS Villanova, PA. 1997.
   Google Scholar
• Edmond MB. Multidrug resistant enterococci and the threat of vancomycin-resistant Staphylococcus aureus. In Wenzel RP ed.: Prevention and control of nosocomial infec-tions, 3rd edition, Philadelphia, WB Saunders, 1997: 339-355.
   Google Scholar
• Centers for Disease Control. Recommendations for pre-venting the spread of vancomycin resistance. Recommendations of the hospital infection control practices advisory committee (HICPAC). MMWR 1995; 44: 1–13.
   Google Scholar
• Karanfil LV, Murphy M, Josephson A, et al. A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit. Infect Control Hosp Epidemiol 1992; 13: 195–200.
   PubMed Web of Science ®Google Scholar
• Handwerger S, Raucher B, Altarac D, et al. Nosocomial outbreak due to Enterococcus faecium highly resistant to van-comycin, penicillin, and gentamicin. Clin Infect Dis 1993; 16: 750–755.
   PubMed Web of Science ®Google Scholar
• Boyle JF, Soumakis SA, Rendo A, et al. Epidemiological analysis and genotypic characterization of a nosocomial out-break of vancomycin-resistant enterococci. J Clin Microb 1993; 31: 1280–1285.
   PubMed Web of Science ®Google Scholar
• Montecalvo MA, Horowitz H, Gedris C, et al. Outbreak of vancomycin-, ampicillin-, and aminoglyciside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrob Agents Chemother 1994; 38: 1363–1367.
   PubMed Web of Science ®Google Scholar
• Boyce JM, Opal SM, Chow JW, et al. Outbreak of multi-drug resistant Enterococcus faecium with transferable van-B class vancomycin resistance. J Clin Microbiol 1994; 32: 1148–1153.
   PubMed Web of Science ®Google Scholar
• Venditti M, Biavasco F, Varaldo PE, et al. Catheter-related endocarditis due to glycopeptide-resistant Enterococcus faecalis in a transplanted heart. Clin Infect Dis 1993; 17: 524–525.
   PubMed Web of Science ®Google Scholar
• Yelamanchili S, Cunliffe NA, Miles RS. Prosthetic valve endocarditis caused by a vancomycin-resistant Enterococcus faecalis. J Infect 1998; 36: 348–349.
   PubMed Web of Science ®Google Scholar
• Vijayvargiya R, Veis JH. Antibiotic-resistant endocardi-tis in a hemodialysis patient. J Am Soc Nephrol 1996; 7: 536–542.
   PubMed Web of Science ®Google Scholar
• Furlang WB, Rakowski TA. Therapy with RP 59500 (quinupristin/dalfopristin) for prosthetic valve endocarditis due to enterococci with vanA/vanB resistance patterns. Clin Infect Dis 1997; 25: 163–164.
   PubMed Web of Science ®Google Scholar
• Matsumura S, Simor AE. Treatment of endocarditis due to vancomycin-resistant Enterococcus faecium with quin-upristin/dalfopristin, doxycycline, and rifampin: a synergistic drug combination. Clin Infect Dis 1998; 27: 1554–1556.
   PubMed Web of Science ®Google Scholar
• Venditti M, Tarasi A, Gelfusa V, Nicastri E, Penni A, Martino P. Antimicrobial susceptibilities of enterococci isolated from hospitalized patients. Antimicrob Agents Chemother 1993; 37: 1190–1192.
   PubMed Web of Science ®Google Scholar
• Bates J. Epidemiology of vanconycin-resistant entero-cocci in the community and the relevance of farm animals to human infection. J Hosp Infect 1997; 37: 89–101.
   PubMed Web of Science ®Google Scholar
• Murray BE. The life and times of the enterococcus. Clin Microbiol Rev 1990; 3: 46–65.
   PubMed Web of Science ®Google Scholar
• Lefort A, Baptista M, Fantin B, et al. Two-step acquisi-tion of resistance to teicoplanin-gentamicin combination by van-B type Enterococcus faecalis in vitro and in experimental endocarditis. Antimicrob Agents Chemother 1999; 43: 476–482.
   PubMed Web of Science ®Google Scholar
• Linden PK. Quinupristin/dalfopristin: a new therapeutic alternative for the treatment of vancomycin-resistant Enterococcus faecium and other serious Gram-positive infec-tions. Today's Therapeutic Trends 1997; 15: 137–153.
   Google Scholar
• Venditti M, Goglio A, and the GIMEMA Microbiology Group. Vancomycin susceptibility in enterococcal blood iso-lates in Italy: a multicenter retrospective analysis. J Chemother 1996; 8: 33–36.
   Google Scholar
• Fontana R, Ligorri M, Mazzariol A, Veneri G, Cornaglia G, and the Italian Surveillance Group of Antimicrobial Resistance. Resistance of enterococci to ampi-cillin and glycopeptide antibiotics in Italy. Clin Infect Dis 1998; 27 (Supp11): S84-S86.
   Google Scholar
• Rice LB, Calderwood SB, Eliopoulos GM, et al. Enterococcal endocarditis. A comparison of prosthetic and native valve disease. Rev Infect Dis 1991; 13: 1–7.
   PubMedGoogle Scholar
• Breen JD, Thauvin-Eliopoulos C, Eliopoulos GM, Moellering RC. Activity of new semisynthetic glycopeptides against vancomycin resistant organism. In Abstracts of the 35th ICAAC San Francisco, CA, Washington, DC. American Society for Microbiology, 1995. Abstract F253, p. 157.
   Google Scholar
• Zaman MM, Landman D, Burney S, Quale JM. Treatment of experimental endocarditis due to multidrug-resis-tant Enterococcus faecium with clinafloxacin and penicillin. J Antimicrob Chemother 1996; 37: 127–132.
   PubMed Web of Science ®Google Scholar
• Eliopoulos GM, Wennersten CB, Moellering RC. Activities of new oxazolidinone antimicrobials against entero-cocci. In Abstracts of the 35th ICAAC San Francisco, CA. American Society for Microbiology, Washington, DC. 1995. Abstract F217, p. 151.
   Google Scholar